Achilles Therapeutics PLC ADR (ACHL) Key Ratios

Stock Card

$1.48

$0.00 (0.00%)

As on 26-Mar-2025 09:30EDT

Market cap

$63 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.6

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	--	--	--
EBIT	--	--	59.87	13.26	-187.43
Net Profit	-19.63	-17.45	10.95	-7.12	-225.97
EPS	-19.63	-17.45	11.67	24.26	--
Book Value	--	--	-29.55	-73.41	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-23	Dec-22
EBIT-Margin	--	--	--	--	--
Net Margin	--	--	--	--	--
Return on equity	-31.94	-28.64	-57.28	-41.05	-29.26
Return on Capital	-30.55	-27.54	--	-39.51	-28.05
Return on Assets	-28.59	-25.95	-39.96	-36.49	-26.49
Debt to Equity (x)	--	--	0.00	0.03	0.04

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	-39.51	-28.05	-24.10	-21.61
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-57.28

Lower than Peers by 16.95

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	-57.28	-41.05	-29.26	-25.52	-22.84
Peer Median	-40.33	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-39.96

Lower than Peers by 8.72

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	-39.96	-36.49	-26.49	-22.80	-20.49
Peer Median	-31.24	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

59.87

Higher than Peers by 60.88

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	59.87	8.40	-34.42	-80.99	-144.86
Peer Median	-1.02	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

10.95

Higher than Peers by 18.48

Year on year growth in profit after tax

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	10.95	2.12	-16.49	-84.04	-137.31
Peer Median	-7.53	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

11.67

Lower than Peers by 2.56

Year on year growth in earnings per share

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	11.67	0.05	0.13	0.94	--
Peer Median	14.23	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

-32.80

Lower than Peers by 22.67

Year on year growth in book value per share

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	-32.80	--	--	--	--
Peer Median	-10.13	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

Total debt / Net worth

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	0.03	0.04	0.04	0.08
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.04

(Short term borrowings / Net worth)

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	0.04	0.02	0.02	0.02	0.02
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

6.04

Higher than Peers by 0.23

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	6.04	8.57	10.93	14.90	11.30
Peer Median	5.81	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

6.04

Higher than Peers by 0.35

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	6.04	8.57	10.67	14.63	11.19
Peer Median	5.70	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	--	-11.21	-19.49	-63.53
Peer Median	-2.09	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

Sales / Average Total Assets

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	--	--	--	--
Peer Median	0.06	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	178.48	483.19	382.79	530.97
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	417.49	441.20	557.49	1,693.85
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	-0.51	-0.49	-2.38	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

0.61

Lower than Peers by 4.72

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	0.61	0.25	0.18	0.50	--
Peer Median	5.33	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

1.66

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	1.66	1.30	1.65	1.88	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

Lower than Peers by 78

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-23	Dec-22	Dec-21	Dec-20
Achilles Therapeutics PLC ADR (ACHL)	63	--	--	--	--
Peer Median	142	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly